🔴 Anixa Biosciences is trading 7.05% down in pre-market

Anixa Biosciences is trading at $2.90, down 7.05% in pre-market, with no new company-specific announcement identified to explain the decline.

• The latest listed company release was dated October 26.
• An October 13 announcement said its CAR-T therapy inventor would speak at a November 2–3 conference; the previously announced event does not establish a cause for the drop.
• Supplied indices are higher in pre-market, and the move follows a 5.45% decline on October 30.